UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 9.008

Sortiert nach

1047P Efficacy of checkpoint inhibitors (CPIs) in acral melanoma (AM)

Annals of oncology, 2021-09, Vol.32, p.S876-S877

2021

Link zum Volltext

Verfügbarkeit prüfen

MO404ACUTE KIDNEY INJURY DUE TO IMMUNE CHECKPOINT INHIBITORS (CPIS) NEPHROTOXICITY

Nephrology, dialysis, transplantation, 2021-05, Vol.36 (Supplement_1)

2021

Link zum Volltext

Verfügbarkeit prüfen

Novel rigid semi-alicyclic dianhydride with large side groups for high performance colorless polyimides (CPIs)

Polymer testing, 2023-12, Vol.129, p.108269, Article 108269

2023

Link zum Volltext

Verfügbarkeit prüfen

Immune related adverse events (irAEs) in patients with solid tumors and advanced chronic kidney disease (CKD) receiving checkpoint inhibitors (CPIs)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.2650-2650

2023

Link zum Volltext

Verfügbarkeit prüfen

CD8 cell PET imaging with 89-Zr-crefmirlimab berdoxam (crefmirlimab) in patients with metastatic renal cell carcinoma (mRCC) receiving checkpoint inhibitors (CPIs): Association with response and tissue CD8 expression

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.4551-4551

2023

Link zum Volltext

Verfügbarkeit prüfen

Thromboembolism (TE) in patients (pts) with bladder cancer treated with checkpoint inhibitors (CPIs)

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.5042-5042

2020

Link zum Volltext

Verfügbarkeit prüfen

Exploratory analysis of predictive biomarkers for immune-related adverse events (irAEs) due to checkpoint inhibitors (CPIs) in patients with genitourinary (GU) cancers

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.569-569

2023

Link zum Volltext

Verfügbarkeit prüfen

The feasibility of procalcitonin and CPIS score to reduce inappropriate antibiotics use among severe-critically ill COVID-19 pneumonia patients: A pilot study

American journal of infection control, 2022-05, Vol.50 (5), p.581-584

2022

Link zum Volltext

Verfügbarkeit prüfen

Methyl jasmonate (MeJA) mediates expression of cysteine proteases (CysProts) and their inhibitors (CPIs)-related genes and programmed cell death (PCD) during apple ripening

Scientia horticulturae, 2024-03, Vol.328, p.112936, Article 112936

2024

Link zum Volltext

Verfügbarkeit prüfen

Real-world outcome study among patients with renal cell carcinoma (RCC) receiving checkpoint inhibitors (CPIs)

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e16073-e16073

2019

Link zum Volltext

Verfügbarkeit prüfen

The role of procalcitonin and Clinical Pulmonary for Infection Score (CPIS) score to reduce inappropriate antibiotics use among moderate to severe coronavirus disease 2019 (COVID-19) pneumonia: A quasi-experimental multicenter study

Infection control and hospital epidemiology, 2023-07, Vol.44 (7), p.1199-1203

2023

Link zum Volltext

Verfügbarkeit prüfen

Concordance between the National Healthcare Safety Network (NHSN) Surveillance Criteria and Clinical Pulmonary Infection Score (CPIS) Criteria for Diagnosis of Ventilator-associated Pneumonia (VAP)

Indian journal of critical care medicine, 2021-03, Vol.25 (3), p.296-298

2021

Link zum Volltext

Verfügbarkeit prüfen

PO-0744 Efficacy of single-fraction or fractionated SRS combined with CPIs in melanoma brain metastases

Radiotherapy and oncology, 2019-04, Vol.133, p.S382-S382

2019

Link zum Volltext

Verfügbarkeit prüfen

CPIS

A Dictionary of Abbreviations, 2011

Burt Vance

1, 2011

Link zum Volltext

Verfügbarkeit prüfen

A phase Ib trial of anti-VEGFR/PDGFR vorolanib combined with immune checkpoint inhibitors (CPIs) in solid tumors

Journal of clinical oncology, 2019-02, Vol.37 (4_suppl), p.TPS472-TPS472

2019

Link zum Volltext

Verfügbarkeit prüfen

Association of baseline characteristics and survival in patients with advanced non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (CPIs): Real-world evidence

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e21625-e21625

2020

Link zum Volltext

Verfügbarkeit prüfen

Comprehensive immune profiling of patients (pts) with metastatic urothelial cancer (mUC) or renal cell cancer (mRCC) receiving immune checkpoint inhibitors (CPIs)

Journal of clinical oncology, 2020-02, Vol.38 (6_suppl), p.532-532

2020

Link zum Volltext

Verfügbarkeit prüfen

489: DIAGNOSTIC ACCURACY OF MODIFIED CPIS WITHOUT CHEST RADIOGRAPHS COMPARED TO FULL CPIS

Critical care medicine, 2012-12, Vol.40, p.1-328

2012

Link zum Volltext

Verfügbarkeit prüfen

A comparison of APACHE II and CPIS scores for the prediction of 30-day mortality in patients with ventilator-associated pneumonia

International journal of infectious diseases, 2015-01, Vol.30 (C), p.144-147

2015

Link zum Volltext

Verfügbarkeit prüfen

The impact of pretreatment absolute lymphocyte count (pALC) and neutrophil-lymphocyte ratio (pNLR) on checkpoint inhibitors (CPIs) response rates in renal cell carcinoma (RCC) and bladder urothelial cancers (BC)

Journal of clinical oncology, 2020-02, Vol.38 (5_suppl), p.29-29

2020

Link zum Volltext

Verfügbarkeit prüfen

CPIS Lung Ultrasound and the Erratic March toward Diagnostic Certainty in VAP

Indian journal of critical care medicine, 2021-03, Vol.25 (3), p.255-257

Rajagopalan, Ram E

2021

Link zum Volltext

Verfügbarkeit prüfen

CaboPoint, a phase II, open-label study of cabozantinib as second-line therapy for patients with clear cell metastatic renal cell carcinoma (RCC), whose disease progressed after therapy with checkpoint inhibitors (CPIs)

Journal of clinical oncology, 2020-02, Vol.38 (6_suppl), p.TPS772-TPS772

2020

Link zum Volltext

Verfügbarkeit prüfen

Treatment-related side effects as predictors of efficacy of check-point inhibitors (CPIs)

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.3062-3062

2016

Link zum Volltext

Verfügbarkeit prüfen

PCN317 REAL-WORLD STUDY OF METASTATIC MERKEL CELL CARCINOMA PATIENTS RECEIVING CHECKPOINT INHIBITORS (CPIS) VS. CHEMOTHERAPY TREATMENTS

Value in health, 2019-05, Vol.22, p.S117-S117

2019

Link zum Volltext

Verfügbarkeit prüfen

Real-world clinical and economic outcomes among newly-diagnosed merkel cell carcinoma (MCC) patients initiating first-line (1L) checkpoint inhibitors (CPIs) or chemotherapy (CT) in the veterans health administration (VHA)

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e21002-e21002

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 9.008

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(6.161)
Mit Volltextzugriff
(8.229)

Publikationsform

8 weitere anzeigen...

Weniger anzeigen...

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(4.220)
Ingenta.com
(2.948)
IngentaConnect Journals
(2.038)
EBSCOhost Business Source Ultimate
(1.378)
Journals@Ovid Complete
(1.276)
Springer journals
(1.052)
Standalone journals
(886)
Wiley Online Library - AutoHoldings Journals
(826)
Nexis Uni
(615)
Ebook Central Perpetual and DDA
(598)
Wiley Online Library
(589)
Jstor Complete Legacy
(588)
eBooks on EBSCOhost
(567)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(553)
Taylor & Francis Current Content Access
(508)
Factiva
(481)
Taylor & Francis Journals Complete
(470)
Elsevier ScienceDirect Journals Complete
(408)
PAIS Index
(345)
Sociological Abstracts
(311)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Ppi Detailed Report
(216)
Journal Of Clinical Oncology
(130)
Cpi Detailed Report
(95)
Energies
(84)
Journal For Immunotherapy Of Cancer
(84)
Ciência & Saude Coletiva
(77)
Cancers
(66)
Pr Newswire
(61)
Plos One
(58)
Intensive Care Medicine
(53)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

1047P Efficacy of checkpoint inhibitors (CPIs) in acral melanoma (AM)

MO404ACUTE KIDNEY INJURY DUE TO IMMUNE CHECKPOINT INHIBITORS (CPIS) NEPHROTOXICITY

Novel rigid semi-alicyclic dianhydride with large side groups for high performance colorless polyimides (CPIs)

Immune related adverse events (irAEs) in patients with solid tumors and advanced chronic kidney disease (CKD) receiving checkpoint inhibitors (CPIs)

CD8 cell PET imaging with 89-Zr-crefmirlimab berdoxam (crefmirlimab) in patients with metastatic renal cell carcinoma (mRCC) receiving checkpoint inhibitors (CPIs): Association with response and tissue CD8 expression

Thromboembolism (TE) in patients (pts) with bladder cancer treated with checkpoint inhibitors (CPIs)

Exploratory analysis of predictive biomarkers for immune-related adverse events (irAEs) due to checkpoint inhibitors (CPIs) in patients with genitourinary (GU) cancers

The feasibility of procalcitonin and CPIS score to reduce inappropriate antibiotics use among severe-critically ill COVID-19 pneumonia patients: A pilot study

Methyl jasmonate (MeJA) mediates expression of cysteine proteases (CysProts) and their inhibitors (CPIs)-related genes and programmed cell death (PCD) during apple ripening

Real-world outcome study among patients with renal cell carcinoma (RCC) receiving checkpoint inhibitors (CPIs)

The role of procalcitonin and Clinical Pulmonary for Infection Score (CPIS) score to reduce inappropriate antibiotics use among moderate to severe coronavirus disease 2019 (COVID-19) pneumonia: A quasi-experimental multicenter study

Concordance between the National Healthcare Safety Network (NHSN) Surveillance Criteria and Clinical Pulmonary Infection Score (CPIS) Criteria for Diagnosis of Ventilator-associated Pneumonia (VAP)

PO-0744 Efficacy of single-fraction or fractionated SRS combined with CPIs in melanoma brain metastases

CPIS

A phase Ib trial of anti-VEGFR/PDGFR vorolanib combined with immune checkpoint inhibitors (CPIs) in solid tumors

Association of baseline characteristics and survival in patients with advanced non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (CPIs): Real-world evidence

Comprehensive immune profiling of patients (pts) with metastatic urothelial cancer (mUC) or renal cell cancer (mRCC) receiving immune checkpoint inhibitors (CPIs)

489: DIAGNOSTIC ACCURACY OF MODIFIED CPIS WITHOUT CHEST RADIOGRAPHS COMPARED TO FULL CPIS

A comparison of APACHE II and CPIS scores for the prediction of 30-day mortality in patients with ventilator-associated pneumonia

The impact of pretreatment absolute lymphocyte count (pALC) and neutrophil-lymphocyte ratio (pNLR) on checkpoint inhibitors (CPIs) response rates in renal cell carcinoma (RCC) and bladder urothelial cancers (BC)

CPIS Lung Ultrasound and the Erratic March toward Diagnostic Certainty in VAP

CaboPoint, a phase II, open-label study of cabozantinib as second-line therapy for patients with clear cell metastatic renal cell carcinoma (RCC), whose disease progressed after therapy with checkpoint inhibitors (CPIs)

Treatment-related side effects as predictors of efficacy of check-point inhibitors (CPIs)

PCN317 REAL-WORLD STUDY OF METASTATIC MERKEL CELL CARCINOMA PATIENTS RECEIVING CHECKPOINT INHIBITORS (CPIS) VS. CHEMOTHERAPY TREATMENTS

Real-world clinical and economic outcomes among newly-diagnosed merkel cell carcinoma (MCC) patients initiating first-line (1L) checkpoint inhibitors (CPIs) or chemotherapy (CT) in the veterans health administration (VHA)

Suchergebnisse filtern